---
schema_version: "secwatch.filing_event.v1"
accession: "0001447362-22-000109"
form_type: "8-K"
ticker: "CSTL"
cik: "0001447362"
company_name: "CASTLE BIOSCIENCES INC"
filed_at: "2022-06-08T23:59:59+00:00"
generated_at: "2026-06-25T03:29:42.788032+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.5
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Stockholders reject advisory say-on-pay proposal at Castle Biosciences annual meeting

## Summary
- Say-on-pay failed: 8,331,458 For vs 11,985,739 Against; broker non-votes 1,869,015.
- Class III directors Kimberlee S. Caple, G. Bradley Cole, and Derek J. Maetzold re-elected.
- Ratified KPMG LLP as independent auditor for fiscal year 2022 (22,499,340 For).
- Advisory vote on frequency: 20,368,320 preferred 1 year; board will hold annual say-on-pay votes.

## SEC filing metadata
- accession: 0001447362-22-000109
- form_type: 8-K
- ticker: CSTL
- cik: 0001447362
- company_name: CASTLE BIOSCIENCES INC
- filed_at: 2022-06-08T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.5
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1447362/000144736222000109/0001447362-22-000109-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1447362/000144736222000109/cstl-20220602.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001447362-22-000109
- JSON: https://secwatch.observer/filing/0001447362-22-000109.json
- Plain text: https://secwatch.observer/filing/0001447362-22-000109.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.